Eugènia Negredo

8.3k total citations
186 papers, 4.8k citations indexed

About

Eugènia Negredo is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Eugènia Negredo has authored 186 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Infectious Diseases, 109 papers in Virology and 95 papers in Emergency Medicine. Recurrent topics in Eugènia Negredo's work include HIV/AIDS drug development and treatment (112 papers), HIV Research and Treatment (109 papers) and HIV-related health complications and treatments (95 papers). Eugènia Negredo is often cited by papers focused on HIV/AIDS drug development and treatment (112 papers), HIV Research and Treatment (109 papers) and HIV-related health complications and treatments (95 papers). Eugènia Negredo collaborates with scholars based in Spain, United States and Netherlands. Eugènia Negredo's co-authors include Bonaventura Clotet, Jordi Puig, Núria Pérez‐Álvarez, Anna Bonjoch, Roger Paredes, José Moltó, Carmina R. Fumaz, Guillem Sirera, Joan Romeu and Julià Blanco and has published in prestigious journals such as Annals of Internal Medicine, The Journal of Immunology and PLoS ONE.

In The Last Decade

Eugènia Negredo

179 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eugènia Negredo Spain	39	3.2k	2.5k	1.9k	804	264	186	4.8k
Patrick Mallon Ireland	38	2.2k 0.7×	1.6k 0.6×	2.1k 1.1×	804 1.0×	217 0.8×	198	4.2k
Ferdinand W.N.M. Wit Netherlands	34	2.2k 0.7×	1.8k 0.7×	1.5k 0.8×	1.0k 1.3×	196 0.7×	109	3.6k
Sharon A. Riddler United States	34	2.9k 0.9×	2.6k 1.0×	1.8k 0.9×	751 0.9×	511 1.9×	95	4.4k
Colleen Hadigan United States	44	2.8k 0.9×	2.3k 0.9×	4.7k 2.5×	1.2k 1.4×	244 0.9×	131	6.8k
Heather J. Ribaudo United States	34	3.2k 1.0×	2.4k 0.9×	1.6k 0.8×	658 0.8×	106 0.4×	112	4.4k
Kees Brinkman Netherlands	39	3.8k 1.2×	2.3k 0.9×	2.4k 1.2×	1.7k 2.2×	430 1.6×	139	6.0k
Edgar T. Overton United States	44	2.5k 0.8×	1.5k 0.6×	2.5k 1.3×	1.9k 2.3×	321 1.2×	194	5.6k
Frank A. Post United Kingdom	38	3.6k 1.1×	1.3k 0.5×	2.1k 1.1×	1.6k 2.0×	179 0.7×	185	4.8k
Michael P. Dubé United States	33	1.9k 0.6×	1.2k 0.5×	1.5k 0.8×	926 1.2×	121 0.5×	96	3.2k
Chloe Orkin United Kingdom	39	3.8k 1.2×	2.7k 1.1×	1.8k 0.9×	1.8k 2.3×	129 0.5×	168	6.0k

Countries citing papers authored by Eugènia Negredo

Since Specialization

Citations

This map shows the geographic impact of Eugènia Negredo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugènia Negredo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugènia Negredo more than expected).

Fields of papers citing papers by Eugènia Negredo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugènia Negredo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugènia Negredo. The network helps show where Eugènia Negredo may publish in the future.

Co-authorship network of co-authors of Eugènia Negredo

This figure shows the co-authorship network connecting the top 25 collaborators of Eugènia Negredo. A scholar is included among the top collaborators of Eugènia Negredo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugènia Negredo. Eugènia Negredo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Negredo, Eugènia, Vicenç Falcó, Àngel Rivero, et al.. (2025). Exploring the acceptability, appropriateness, feasibility and satisfaction of an implementation strategy for out-of-HOspital administration of the Long-Acting combination of cabotegravir and rilpivirine as an optional therapy for HIV in Spain (the HOLA study)—a hybrid implementation-effectiveness, phase IV, double-arm, open-label, multicentric study: study protocol. BMJ Open. 15(4). e088514–e088514.

Alagaratnam, Jasmini, Kathrin van Bremen, Georg M. N. Behrens, et al.. (2025). Statin use in HIV: European AIDS Clinical Society guidance for the primary prevention of cardiovascular disease. The Lancet HIV. 12(5). e382–e392. 5 indexed citations

Loste, Cora, Víctor Urrea, Ana Raquel Ortega Martínez, et al.. (2024). Immunoaging at Early Ages Could Drive a Higher Comorbidity Burden in People with HIV on Antiretroviral Therapy Compared with the Uninfected Population. International Journal of Molecular Sciences. 25(20). 10930–10930. 1 indexed citations

Santos, José Ramón, María Saumoy, Adrián Curran, et al.. (2015). The Lipid-Lowering Effect of Tenofovir/Emtricitabine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial. Clinical Infectious Diseases. 61(3). 403–408. 96 indexed citations

Negredo, Eugènia, Jordi Puig, Patricia Echeverría, et al.. (2015). Ten-Year Safety with Polyacrylamide Gel Used to Correct Facial Lipoatrophy in HIV-Infected Patients. AIDS Research and Human Retroviruses. 31(8). 817–821. 9 indexed citations

Guardiola, Montse, Patricia Echeverría, Marta Domínguez‐Gil González, et al.. (2015). Polymorphisms in LPL , CETP , and HL Protect HIV-Infected Patients from Atherogenic Dyslipidemia in an Allele-Dose-Dependent Manner. AIDS Research and Human Retroviruses. 31(9). 882–888. 5 indexed citations

Torres, Berta, Norma Rallón, Montserrat Loncà, et al.. (2013). Immunological Function Restoration with Lopinavir/Ritonavir Versus Efavirenz Containing Regimens in HIV-Infected Patients: A Randomized Clinical Trial. AIDS Research and Human Retroviruses. 30(5). 425–433. 8 indexed citations

Pulido, Federico, Mauro Schechter, Eugènia Negredo, et al.. (2011). Effectiveness of Protease Inhibitor Monotherapy versus Combination Antiretroviral Maintenance Therapy: A Meta-Analysis. PLoS ONE. 6(7). e22003–e22003. 71 indexed citations

Moltó, José, Marta Valle, José Ramón Santos, et al.. (2010). Efficacy and Safety of Ritonavir Dose Reduction Based on the Tipranavir Inhibitory Quotient in HIV-Infected Patients on Salvage Antiretroviral Therapy with Tipranavir/Ritonavir. AIDS Research and Human Retroviruses. 26(11). 1191–1196. 1 indexed citations

10.

Ferrer, Elena, Luis del Río, Estebán Martínez, et al.. (2010). Impact of Switching from Lopinavir/Ritonavir to Atazanavir/Ritonavir on Body Fat Redistribution in Virologically Suppressed HIV-Infected Adults. AIDS Research and Human Retroviruses. 27(10). 1061–1065. 13 indexed citations

11.

Negredo, Eugènia, Jordi Puig, Manuel Medina, et al.. (2009). Four-Year Safety with Polyacrylamide Hydrogel to Correct Antiretroviral-Related Facial Lipoatrophy. AIDS Research and Human Retroviruses. 25(4). 451–455. 25 indexed citations

12.

Lazzari, Elisa de, Agathe León, Estebán Martínez, et al.. (2008). Hepatotoxicity of nevirapine in virologically suppressed patients according to gender and CD4 cell counts^*. HIV Medicine. 9(4). 221–226. 41 indexed citations

13.

Muñoz-Moreno, José A., Carmina R. Fumaz, María José Ferrer, et al.. (2008). Nadir CD4 Cell Count Predicts Neurocognitive Impairment in HIV-Infected Patients. AIDS Research and Human Retroviruses. 24(10). 1301–1307. 80 indexed citations

14.

Muñoz-Moreno, José A., Carmina R. Fumaz, María José Ferrer, et al.. (2007). Assessing Self-Reported Adherence to HIV Therapy by Questionnaire: The SERAD (Self-Reported Adherence) Study. AIDS Research and Human Retroviruses. 23(10). 1166–1175. 39 indexed citations

15.

Negredo, Eugènia. (2006). Benefits and concerns of simplification strategies in HIV-infected patients. Journal of Antimicrobial Chemotherapy. 58(2). 235–242. 32 indexed citations

16.

López, Sònia, Eugènia Negredo, Glòria Garrabou, et al.. (2006). Longitudinal Study on Mitochondrial Effects of Didanosine–Tenofovir Combination. AIDS Research and Human Retroviruses. 22(1). 33–39. 20 indexed citations

17.

Moltó, José, Lı́dia Ruiz, Joan Romeu, et al.. (2004). Influence of Prior Structured Treatment Interruptions on the Length of Time without Antiretroviral Treatment in Chronically HIV-Infected Subjects. AIDS Research and Human Retroviruses. 20(12). 1283–1288. 12 indexed citations

18.

Negredo, Eugènia, et al.. (2001). Pneumonia varicellosa in the adult: Study of nine cases. Anales de Medicina Interna. 18(6). 30–36. 3 indexed citations

19.

Tuldrà, Albert, Carmina R. Fumaz, Ramón Bayés, et al.. (2000). Prospective Randomized Two-Arm Controlled Study To Determine the Efficacy of a Specific Intervention To Improve Long-Term Adherence to Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 25(3). 221–228. 197 indexed citations

20.

Romeu, Joan, G. Sirera, Moacyr Jesus Barreto de Melo Rêgo, et al.. (1999). Cumulative risk for developing hyperlipidemia in HIV-infected patients treated with protease inhibitors. 39. 498. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact